Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Prognostic Imaging Biomarkers for Diabetic Kidney Disease (iBEAt): Study protocol

View ORCID ProfileKim M Gooding, Chrysta Lienczewski, Massimo Papale, Niina Koivuviita, Marlena Maziarz, Anna-Maria Dutius Andersson, Kanishka Sharma, Paola Pontrelli, Alberto Garcia Hernandez, Julie Bailey, Kay Tobin, Virva Saunavaara, Anna Zetterqvist, David Shelley, Irvin Teh, Claire Ball, Sapna Puppala, Mark Ibberson, Anil Karihaloo, Kaj Metsärinne, Rosamonde Banks, Peter S Gilmour, Michael Mansfield, Mark Gilchrist, Dick de Zeeuw, Hiddo J.L. Heerspink, Pirjo Nuutila, Matthias Kretzler, Matthew Wellberry-Smith, Loreto Gesualdo, Dennis Andress, Nicolas Grenier, Angela C Shore, Maria F. Gomez, Steven Sourbron, iBEAt investigators
doi: https://doi.org/10.1101/2020.01.13.20017228
Kim M Gooding
1Diabetes and Vascular Medicine, University of Exeter Medical School, Exeter, UK
2NIHR Exeter Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kim M Gooding
Chrysta Lienczewski
3Department of Nephrology, University of Michigan, Ann Arbor, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Massimo Papale
4Department of Emergency and Organ Transplantation, Nephrology Unit, University of Bari, Bari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niina Koivuviita
5Department of Medicine, Division of Nephrology, Turku University Hospital, Turku, Finland
6Turku PET Centre, University of Turku, Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marlena Maziarz
7Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna-Maria Dutius Andersson
7Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kanishka Sharma
8Department of Biomedical Imaging Sciences, University of Leeds, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paola Pontrelli
3Department of Nephrology, University of Michigan, Ann Arbor, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Garcia Hernandez
9Astellas Pharma Europe B.V.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Bailey
10Leeds Teaching Hospitals NHS Trust, Leeds, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kay Tobin
11Department of Renal Medicine and Renal Transplantation, Leeds Teaching Hospitals NHS Trust, Leeds, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virva Saunavaara
12Department of Medical Physics, Division of Medical Imaging, Turku University Hospital, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Zetterqvist
7Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Shelley
10Leeds Teaching Hospitals NHS Trust, Leeds, UK
13Advanced Imaging Centre, University of Leeds, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irvin Teh
8Department of Biomedical Imaging Sciences, University of Leeds, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire Ball
1Diabetes and Vascular Medicine, University of Exeter Medical School, Exeter, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sapna Puppala
10Leeds Teaching Hospitals NHS Trust, Leeds, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Ibberson
14Swiss Institute of Bioinformatics, Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anil Karihaloo
15Novo Nordisk Research Center Seattle, Inc., Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaj Metsärinne
5Department of Medicine, Division of Nephrology, Turku University Hospital, Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosamonde Banks
16Leeds Institute of Medical Research at St James’s, University of Leeds, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter S Gilmour
17The Drug Development Team, Leiden, Holland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Mansfield
10Leeds Teaching Hospitals NHS Trust, Leeds, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Gilchrist
1Diabetes and Vascular Medicine, University of Exeter Medical School, Exeter, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dick de Zeeuw
18Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen
19University of Groningen, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiddo J.L. Heerspink
18Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen
19University of Groningen, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pirjo Nuutila
5Department of Medicine, Division of Nephrology, Turku University Hospital, Turku, Finland
6Turku PET Centre, University of Turku, Turku, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Kretzler
3Department of Nephrology, University of Michigan, Ann Arbor, USA
20Computational Medicine and Bioinformatics, University of Michigan, Ann Arbour, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Wellberry-Smith
11Department of Renal Medicine and Renal Transplantation, Leeds Teaching Hospitals NHS Trust, Leeds, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Loreto Gesualdo
3Department of Nephrology, University of Michigan, Ann Arbor, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis Andress
21AbbVie, Scottsdale, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas Grenier
22Service de Radiologie, CHU de Bordeaux, Université de Bordeaux, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela C Shore
1Diabetes and Vascular Medicine, University of Exeter Medical School, Exeter, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria F. Gomez
7Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Sourbron
8Department of Biomedical Imaging Sciences, University of Leeds, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Diabetic kidney disease (DKD) is traditionally classified based on albuminuria and reduced kidney function (estimated glomerular filtration rate (eGFR)), but these have limitations as prognostic biomarkers due to the heterogeneity of DKD. Novel prognostic markers are needed to improve stratification of patients based on risk of disease progression.

The iBEAT study, part of the BEAt-DKD consortium, aims to determine whether renal imaging biomarkers (magnetic resonance imaging (MRI) and ultrasound (US)) provide insight into the pathogenesis and heterogeneity of DKD (primary aim), and whether they have potential as prognostic biomarkers in DKD progression (secondary aim).

iBEAT is a prospective multi-centre observational cohort study recruiting 500 patients with type 2 diabetes (T2D) and eGFR > 30ml/min/1.73m2. At baseline each participant will undergo quantitative renal MRI and US imaging with central processing for MRI images. Blood sampling, urine collection and clinical examinations will be performed and medical history obtained at baseline, and these assessments will be repeated annually for 3 years. Biological samples will be stored in a central laboratory for later biomarker and validation studies. All data will be stored in a central data depository. Data analysis will explore the potential associations between imaging biomarkers and renal function, and whether the imaging biomarkers may improve the prediction of DKD progression rates.

Embedded within iBEAT are ancillary substudies that will (1) validate imaging biomarkers against renal histopathology; (2) validate MRI based renal blood flow against water-labelled positron-emission tomography (PET); (3) develop machine-learning methods for automated processing of renal MRI images; (4) examine longitudinal changes in imaging biomarkers; (5) examine whether the glycocalyx, microvascular function and structure are associated with imaging biomarkers and eGFR decline; (6) a pilot study to examine whether the findings in T2D can be extrapolated to type 1 diabetes.

The iBEAT study, the largest DKD imaging study to date, will provide invaluable insights into the progression and heterogeneity of DKD, and aims to contribute to a more personalized approach to the management of DKD in patients with type 2 diabetes.

Competing Interest Statement

This work forms part of the BEAt-DKD consortium that is funded by the Innovative Medicine Initiative (IMI). AMDA reports grants from Boehringer Ingelheim Pharma GmbH during the conduct of the study. AZ reports non-financial support and other from Boehringer Ingelheim Pharma GmbH during the conduct of the study. M Gilchrist reports personal fees from Lilly outside of the submitted work. DZ reports other from Fresenius, other from Boehringer Ingelheim, other from Bayer, other from Mitsubishi Tanabe, other from Mundipharma, other from Janssen, other from AbbVie, outside the submitted work. HJLH reports other from Merck, other from Mitsubishi Tanabe, grants and other from Janssen, other from Mundipharma, other from Gilead, grants and other from AstraZeneca, grants and other from Abbvie, other from Retrophin, outside the submitted work. MK reports grants from NIH, non-financial support from University of Michigan, during the conduct of the study; grants from JDRF, grants from Astra-Zeneca, grants from NovoNordisc, grants from Eli Lilly, grants from Gilead, grants from Goldfinch Bio, grants from Merck, grants from Janssen, grants from Boehringer-Ingelheim, outside the submitted work; In addition, MK has a patent Biomarkers for CKD progression (encompassing urinary EGF as biomarker of CKD progression) issued. DA reports other from AbbVie, outside the submitted work. M Gomez reports non-financial support and other from Boehringer Ingelheim Pharma GmbH, non-financial support and other from JDRF International, non-financial support and other from Eli Lilly, non-financial support and other from AbbVie, non-financial support and other from Sanofi-Aventis, non-financial support and other from Astellas, non-financial support and other from Novo Nordisk A/S, non-financial support and other from Bayer AG, during the conduct of the study; personal fees from Lilly, non-financial support and other from Novo Nordisk, non-financial support and other from Pfizer, non-financial support and other from Follicum, non-financial support and other from Abcentra, non-financial support from Probi, non-financial support from Johnson & Johnson, outside the submitted work. SS reports non-financial support from Siemens, during the conduct of the study.

Clinical Trial

NCT03716401

Funding Statement

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115974. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA with JDRF.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* Shared senior author

Data Availability

iBEAt investigators are committed to maximise the opportunities for data sharing at study completion in order to increase the lifetime value of their research data as assets for human health and to do so timely, responsibly, in a way consistent with the law, regulation and recognised good practice.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted January 16, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic Imaging Biomarkers for Diabetic Kidney Disease (iBEAt): Study protocol
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Prognostic Imaging Biomarkers for Diabetic Kidney Disease (iBEAt): Study protocol
Kim M Gooding, Chrysta Lienczewski, Massimo Papale, Niina Koivuviita, Marlena Maziarz, Anna-Maria Dutius Andersson, Kanishka Sharma, Paola Pontrelli, Alberto Garcia Hernandez, Julie Bailey, Kay Tobin, Virva Saunavaara, Anna Zetterqvist, David Shelley, Irvin Teh, Claire Ball, Sapna Puppala, Mark Ibberson, Anil Karihaloo, Kaj Metsärinne, Rosamonde Banks, Peter S Gilmour, Michael Mansfield, Mark Gilchrist, Dick de Zeeuw, Hiddo J.L. Heerspink, Pirjo Nuutila, Matthias Kretzler, Matthew Wellberry-Smith, Loreto Gesualdo, Dennis Andress, Nicolas Grenier, Angela C Shore, Maria F. Gomez, Steven Sourbron, iBEAt investigators
medRxiv 2020.01.13.20017228; doi: https://doi.org/10.1101/2020.01.13.20017228
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Prognostic Imaging Biomarkers for Diabetic Kidney Disease (iBEAt): Study protocol
Kim M Gooding, Chrysta Lienczewski, Massimo Papale, Niina Koivuviita, Marlena Maziarz, Anna-Maria Dutius Andersson, Kanishka Sharma, Paola Pontrelli, Alberto Garcia Hernandez, Julie Bailey, Kay Tobin, Virva Saunavaara, Anna Zetterqvist, David Shelley, Irvin Teh, Claire Ball, Sapna Puppala, Mark Ibberson, Anil Karihaloo, Kaj Metsärinne, Rosamonde Banks, Peter S Gilmour, Michael Mansfield, Mark Gilchrist, Dick de Zeeuw, Hiddo J.L. Heerspink, Pirjo Nuutila, Matthias Kretzler, Matthew Wellberry-Smith, Loreto Gesualdo, Dennis Andress, Nicolas Grenier, Angela C Shore, Maria F. Gomez, Steven Sourbron, iBEAt investigators
medRxiv 2020.01.13.20017228; doi: https://doi.org/10.1101/2020.01.13.20017228

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Endocrinology (including Diabetes Mellitus and Metabolic Disease)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (455)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (159)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5297)
  • Forensic Medicine (3)
  • Gastroenterology (198)
  • Genetic and Genomic Medicine (760)
  • Geriatric Medicine (80)
  • Health Economics (214)
  • Health Informatics (702)
  • Health Policy (363)
  • Health Systems and Quality Improvement (224)
  • Hematology (100)
  • HIV/AIDS (165)
  • Infectious Diseases (except HIV/AIDS) (5938)
  • Intensive Care and Critical Care Medicine (368)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (772)
  • Nursing (43)
  • Nutrition (135)
  • Obstetrics and Gynecology (146)
  • Occupational and Environmental Health (234)
  • Oncology (481)
  • Ophthalmology (153)
  • Orthopedics (39)
  • Otolaryngology (97)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (138)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2035)
  • Radiology and Imaging (354)
  • Rehabilitation Medicine and Physical Therapy (159)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)